ClinicalTrials.gg
Sign In

Peripheral Vascular Diseases clinical trials

The registry lists 443 studies for Peripheral Vascular Diseases across more than 10 countries. 44 are recruiting or about to start. 175 of them are mainly about Peripheral Vascular Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 7 narrower conditions too, such as Peripheral Arterial Disease: 2,074 studies, 366 open.

Get an email when these change. Save the Peripheral Vascular Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
263
Status unknown
68
Terminated
43
Recruiting
32
Withdrawn
13
Active, not recruiting
10

Phase

Phase 2
64
Phase 3
54
Phase 1
45
Phase 4
40
Early Phase 1
4

Where

United States
187
Germany
64
Belgium
25
United Kingdom
24
Canada
23
France
22

Who runs them

Abbott Medical Devices (13) · Northwestern University (11) · National Heart, Lung, and Blood Institute (NHLBI) (11) · Flanders Medical Research Program (9) · Medtronic Endovascular (8) · Chengdu University of Traditional Chinese Medicine (7) · W.L.Gore & Associates (6) · C. R. Bard (6)

What is being tested here

Drugs under test in Peripheral Vascular Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Clopidogrel114
Nicotinamide-beta-riboside111
P2Y12 Inhibitor101
Diroximel fumarate101
Fisetin101
Carbon Dioxide111
Treprostinil024
Atorvastatin014
Niacin033
Aspirin002

Drug classes tested here P2Y12 inhibitors 1 open · Statins 7

Coming up

4phase 3 studies under way
16studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 32 Peripheral Vascular Diseases studies recruiting now, 19 (59%) set no upper age limit and 4 (13%) stop at 75 or younger. 2 (6%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 4 (13%) take healthy volunteers.

Recruiting studies that take each age, of 32
AgeWomenMen
102 (6%)2 (6%)
1825 (78%)25 (78%)
3026 (81%)26 (81%)
4024 (75%)24 (75%)
5029 (91%)29 (91%)
6529 (91%)29 (91%)
7529 (91%)29 (91%)
8524 (75%)24 (75%)

Across all 443 studies, recruiting or not: 7% stop at 75 or younger and 2% at 65; 8% take children; <1% are for women only and 1% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Peripheral Vascular Diseases studies take

Of 68 interventional studies with no phase under Peripheral Vascular Diseases, half reached primary completion within 29 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase29 mo16–51 · 68 studies—33 mo16–53 · 48 studies
Observational31 mo8–95 · 25 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 443. Browse all 443 → or search them.